Factors of Importance for the Subjective and Objective Burden of Informal Caregivers to Patients With Functional Psychoses - a Descriptive and Comparative Study
NCT ID: NCT00670371
Last Updated: 2009-11-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2008-03-31
2009-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* To describe clinical characteristics, symptoms, and functioning in the patient group.
* To describe patient resource use in terms of support from the health care and social care sector.
* To describe the socio-economic situation, the general and psychological health, and the coping ability of the informal caregivers.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Patients having the following diagnoses are eligible for inclusion into the study: schizophrenia, schizophreniform disorder, schizoaffective disorder, brief psychotic disorder, delusional disorder, affective psychosis with mood incongruent delusions, psychotic disorder not otherwise specified or patients being actively psychotic.
No interventions assigned to this group
2
Closest relative(s) /informal caregiver(s)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients, male or female, aged 18 years or more, suffering or having suffered from a psychotic episode and being in need of continuous antipsychotic medication.
* The respective patient must have at least one informal caregiver.
* Subjects (patients and informal caregivers) must be able to read and write.
Exclusion Criteria
* Involvement in the planning and conduct of the study (patients and informal caregivers).
* Other concurrent medical condition interfering with ability to complete study (patients and informal caregivers).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
AstraZeneca Pharmaceuticals
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eva Dencker Vansvik
Role: STUDY_DIRECTOR
AstraZeneca, MC, Sweden
Lena Flyckt
Role: PRINCIPAL_INVESTIGATOR
Danderyds Hospital, Stockholm
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research site
Bromma, , Sweden
Research Site
Danderyd, , Sweden
Research Site
Falköping, , Sweden
Research Site
Huddinge, , Sweden
Research Site
Lidingö, , Sweden
Research Site
Ljungby, , Sweden
Research Site
Malmo, , Sweden
Research Site
Solna, , Sweden
Research Site
Stockholm, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-NSE-DUM-2007/1
Identifier Type: -
Identifier Source: org_study_id